Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
ACTH
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
aerobic exercise
alemtuzumab
algorithm
alkylating agents
alopecia
alternative medicine
amantadine
amenorrhea
aminopyridine, 4
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, treatment of
anaphylaxis
anemia
anesthesia, epidural
anesthesia, spinal
anti JC virus antibodies
antihistamines
antineutrophil cytoplasmic autoantibodies
antisense therapy
antispasticity drugs
anxiety
arachnoiditis
arrhythmia, cardiac
asymptomatic
atorvastatin
audiogram
auditory and vestibular pathways
autoimmune disease
axonal degeneration
azathioprine
B cell lymphocyte depletion
B cell lymphocytes
baclofen
bacterial infection
bacterial infection, CNS
Barkhof MR criteria for MS
BENEFIT study
biologic markers
black box warning
bladder dysfunction
blood brain barrier
bone marrow suppression
bone marrow transplantation
botulinum toxin
bradycardia
bradykinesia
brain atrophy
brain biopsy
brain biopsy, false negative
brain biopsy, indication
brain biopsy, negative
brain volume
breast feeding
BTK inhibitors
candida albicans
carbamazepine
carcinoma
carcinoma of breast
cardiomyopathy
cardiotoxicity
CAT scan, chest
central nervous system, infection of
cerebral cortical atrophy
cerebral hypersensitivity, delayed
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
children
chills
cholecystitis
cladribine
clemastine fumarate
Clinical Pathologic Conference(C.P.C.)
clonus
cognition
coinfection
complementary medicine
compliance
complications
conduction block
confusion
congestive heart failure
contrast sensitivity
controversies in neurology
cooling therapy
cop 1
cost
cost effectiveness
cotton-wool spots
cranial neuropathy
cranial neuropathy, multiple
cryptococcal meningitis
cyclophosphamide
cyclosporine
cytokines
cytomegalovirus infection
daclizumab
dantrolene sodium
degenerative diseases of CNS
delay in diagnosis
demyelinating disease
depression
dermatomyositis
dexamethasone suppression test
diagnostic criteria
diaminopyridine, 3, 4
diet
dietary supplement
differential diagnosis
digitalis
dilantin
disability rating scale, neurological
disability, neurological
disease modifying agents
dizziness
dorsal column stimulator
droperidol
drowsiness
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dura, thickened
dysgeusia
echocardiogram
efficacy
ejection fraction
ejection fraction, abnormal
electrocardiogram, abnormal
emotional lability
empyema, epidural
encephalitis, viral
eosinophilia
epidemiology of neurology
epidural steroid
Epstein-Barr virus
Epstein-Barr virus, negative
ethics in neurology
EVIDENCE trial
evidence-based research
evoked potentials
exercise
exercise-induced vascular symptoms
facial weakness
fasciculation
fatigue
fetus
fever
fingolimod
fingolimod, discontinuation
flexor spasm
flicker fusion test
flu-like illness
frexalimab
fumarate
fundus, abnormality of
gadolinium
gag reflex, depressed
gait disorder
gamma amino butyric acid-mimetic drug
gammaglobulin therapy, intravenous
genetic neurologic disorders
granulomatosis with polyangiitis
grasp reflex
gray matter
guanidine
Guillain Barre syndrome
headache
hearing loss
hemophagocytic lymphohistiocytosis
hepatic failure
herniated disc, steroid treatment of
herpes simplex encephalitis
herpes simplex virus
herpes virus
herpes virus infection
herpes zoster
herpes zoster, disseminated
herpes zoster, ophthalmicus
HLA
hot bath test
human herpesvirus 6
hydrocephalus
hydrocephalus, exvacuo
hyperbaric oxygen
hyperbaric treatment
hyperhidrosis
hypersensitivity reaction
hypertension
hyperthermia
hypothermia
iatrogenic neurologic disorders
ibuprofen
idiopathic thrombocytopenic purpura
immune reconstitution inflammatory syndrome
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion body myositis
infection
infliximab
infusion pump
infusion-associated reaction
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon gamma
interferon, intrathecal
interleukin 2
interleukin 6
internet
interobserver agreement
intrathecal antispasticity drugs
intrathecal steroid
intrauterine
intravenous
iron, serum, elevated
Isaacs syndrome
isoniazid
JC virus
laquinimod
leukemia
leukopenia
limbic encephalitis
linomide
listeria monocytogenes
liver disease
liver function enzymes
lymphadenopathy
lymphoma
lymphoma, primary of CNS
lymphopenia
macular edema
mannitol
marihuana
McDonald criteria for MS
meclizine
medication withdrawal
melanoma, malignant
memory, impairment of
meningeal biopsy
meningeal enhancement
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, granulomatous
meningitis, TB
menses
menses, irregular
metallic taste
methotrexate
mimics
misdiagnosis
mitoxantrone
modafinil
monoclonal antibodies
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, black holes on
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength, high
MRI, hypointense signal foci on
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, negative
MRI, optic nerve
MRI, ring sign, open
MRI, serial
MRI, volumetry
MRS
multinucleated giant cell
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, aggressive
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, diet in
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, disease activity
multiple sclerosis, early onset
multiple sclerosis, epidemiology of
multiple sclerosis, etiology of
multiple sclerosis, lesion location
multiple sclerosis, linoleic acid in
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pain in
multiple sclerosis, paroxysmal symptoms in
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, tumefactive
multiple sclerosis, worsening
muscle atrophy, static
muscle pain
muscle stiffness
muscle weakness
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
mycophenolate
myelin basic protein
myocardial injury
myocytolysis
myokymia
N-acetyl-L-aspartic acid
natalizumab
natalizumab, discontinuation
nausea and vomiting
negative
neurofilament light chain protein
neurogenic bladder
neurologic complications
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic examination
neurologic practice
neurologic signs
neurologic symptoms
neurologist
neuromyelitis optica (Devic's disease)
neuromyotonia
neuropathology
neuropathology, brain
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, multifocal
neuropathy, peripheral
neuropathy, peripheral, treatment
neuroprotective agents
neurosyphilis
neurotoxic
neurotoxin
neutralizing antibodies
neutropenia
nevus
nocardiosis
nocturia
nonsteroidal anti-inflammatory drug
ocrelizumab
ofatumumab
opportunistic infection
opportunistic infection, CNS
optic neuritis
optic neuritis, treatment of
optical coherence tomography
organ transplantation
outcome research
oxybutynin
pachymeningitis, cranial
pain
pain, abdominal
pancreatitis
pancytopenia
paraparesis, spastic
paresthesias
Parkinson disease
Parkinson disease, L-dopa nonresponsive
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
paroxysmal neurologic deficits
patient information and support
pemoline
pentoxifylline
pericarditis
personality change
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
pleurisy
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
postpartum
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
primrose oil
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
radiation therapy, CNS treatment and complications with
radiation therapy, total body
radiculopathy
Ramsay Hunt syndrome
rash
rebound
ReBUILD study
recurrent
remyelination
renal failure
research
retinopathy
reversible neurologic disorder
review article
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sedimentation rate, elevated
seizure
serologic testing
seropositive
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
shared decision making
simvastatin
sinemet
skin, lesions in neurologic disorders
spasticity
spasticity, treatment of
spinal cord, injury of
spinal cord, injury, management of
statin therapy
stem cell transplantation
stereotaxic surgery
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
stimulation, deep brain
subspecialist
sweating
sweating, abnormality of
syphilis, neurologic complications with
T cell lymphocytes
tentorium cerebelli
teriflunomide
thalamotomy
thrombocytopenia
tizanidine
tolebrutinib
tolerance
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, surgical treatment of
tremor, thalamic stimulation for suppression of
tremor, treatment of
tricyclic antidepressant
tuberculin skin test, positive
tumor necrosis factor
tumor necrosis factor inhibitor
urinary retention
urinary tract infection
urodynamics
vaccination, neurologic complications with
vaccine
valium
vasopressin
ventricular enlargement
vertigo
vertigo, cervical
vertigo, treatment of
viral infection
viral infection, CNS
viral infection, reactivation
visual acuity
visual acuity, decreased
visual evoked response
visual loss
vitamin D
vitamin supplementation
vitamin, multiple
weakness
web sites
white matter disease
workup
yoga
Showing articles 550 to 600 of 4044 << Previous Next >>

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Clinical Features of MS Associated with Leber Hereditary Optic Neuropathy mtDNA Mutations
Neurol 81:2073-2081, Pfeffer, G.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Interdependence and Contributions of Sun Exposure and Vitamin D to MRI Measures in Multiple Sclerosis
JNNP 84:1075-1081, 1066, Zivadinov, R.,et al, 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013

Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013

Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Disability in Multiple Sclerosis
Neurol 80:1018-1024, Kister, I.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Spinal Cord Lesions in Patients with Clinically Isolated Syndrome
Neurol 80:69-75, Sombekke, M.,et al, 2013

The Thalamus and Multiple Sclerosis
Neurol 80:210-219, Minagar, A.,et al, 2013

Location of Brain Lesions Predicts Conversion of Clinically Isolated Syndromes to Multiple Sclerosis
Neurol 80:234-241, Giorgio, A.,et al, 2013

Functional Impairment in Progressive Supranuclear Palsy
Neurol 80:380-384, Duff, K.,et al, 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013

Cerebral Venous Thrombosis after High Dose Steroid in Multiple Sclerosis: A Case Report
Hippokratia 17:88-90, Gazioglu, S.,et al, 2013

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International ID 735486, Kim, W.,et al, 2012

Brain Atrophy is Related to Lacunar Lesions and Tissue Microstructural Changes in CADASIL
Stroke 38:1786-1790, Jouvent, E.,et al, 2012

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012

Recovery after Spinal Cord Infarcts
Neurol 78:114-121, Robertson,C.E.,et al, 2012

Assessing Abnormal Iron Content in the Deep Gray Matter of Patients with Multiple Sclerosis verus Healthy Controls
AJNR 33:252258, Habib,C.A.,et al, 2012

Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions
Neurol 78:1655-1662, Abou Zeid, N.,et al, 2012

Neuromyelitis Optica and Pregnancy
Neurol 78:875-879, Bourre,B.,et al, 2012

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Should we be nervous about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurologic opinion
JNNP 83:1216-1221, Currie, S.,et al, 2012

Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012

Emerging Subspecialties in Neurology: Neuroimmunology
Neurol 79:e178-e180, Clardy, S., 2012

Monosymptomatic Clinically Isolated Syndrome with Sudden Sensorineural Hearing Loss
The Neurologist 18:302-305, Anagnostouli, M.C.,et al, 2012

Distinct Lesion Morphology at 7-T MRI Differentiates Neuromyelitis Optica from Multiple Sclerosis
Neurol 79:708-714, Sinnecker, T.,et al, 2012

Painful Tonic Spasm in Neuromyelitis Optica
Arch Neurol 69:1026-1031, Kim, S.M.,et al, 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Yellow Fever Vaccination and Increased Relapse Rate in Travelers with Multiple Sclerosis
Arch Neurol 68:1267-1271, Farez, M.F. and Correale, J., 2011

Inflammatory Cortical Demyelination in Early Sclerosis
NEJM 365:2188-2197, Lucchinetti, C.F.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

A Strange Case of Waitress Headache
Lancet 378:1824, Libera, D.D.,et al, 2011

Acute Myeloid Leukemia in Italian Patients with Multiple Sclerosis Treated with Mitoxantrone
Neurol 77:1887-1895, Martinelli, V.,et al, 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
Neurol 77:1644-1645, Iorio, R.,et al, 2011



Showing articles 550 to 600 of 4044 << Previous Next >>